GlobeNewswire Inc | Oct 29, 2021 04:01PM EDT

October 29, 2021

HAMILTON, Bermuda, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Monday, November 1, 2021, at 8:30 a.m. Eastern Time to report its third quarter 2021 financial results and recent portfolio execution.

A live webcast will be accessible through the Investors & Media section of the companys website at www.kiniksa.com. A replay of the webcast will also be available on Kiniksas website within approximately 48 hours of the event. The conference call can be accessed by dialing (866) 614-0636 (U.S.andCanada) or (409) 231-2053 (international) using conference ID number 1699563.

About KiniksaKiniksa is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksas portfolio of assets, ARCALYST (rilonacept), mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved conditions, and offer the potential for differentiation. These assets are designed to modulate immunological pathways across a spectrum of diseases. For more information, please visitwww.kiniksa.com.

ARCALYSTis a registered trademark ofRegeneron Pharmaceuticals,Inc.

Every Second Counts!

Kiniksa Investor and Media ContactRachel Frank(339) 970-9437rfrank@kiniksa.com